APP下载

安非他酮缓释片与帕罗西汀治疗帕金森病抑郁的对照研究

2018-08-31廉鹏孙梦梦冯琳冯晓莉张灿文

中国当代医药 2018年13期
关键词:抑郁生活质量

廉鹏 孙梦梦 冯琳 冯晓莉 张灿文

[摘要]目的 比較安非他酮缓释片和帕罗西汀对改善帕金森病患者抑郁和生活质量的疗效。方法 于2016年2月~2017年9月选取在泰安市精神病院门诊及住院的42例帕金森病抑郁患者,采用随机数字表法分为研究组和对照组,每组各21例。研究组使用安非他酮缓释片治疗,对照组使用帕罗西汀治疗,疗程均为6周。采用汉密尔顿抑郁量表(HAMD)评定抑郁变化程度,帕金森病综合评分(UPDRS)第三分量表评定运动功能,39项帕金森病调查问卷评分(PDQ-39)评定生活质量变化。结果 治疗前,两组的HAMD、UPDRS、PDQ-39评分比较,差异均无统计学意义(P>0.05)。治疗2、4、6周后,两组的HAMD评分均显著低于治疗前,差异有统计学意义(P<0.01),两组的HAMD评分比较,差异无统计学意义(P>0.05);研究组的UPDRS第三分量表、PDQ-39评分第2、4、6周均明显低于治疗前,差异有统计学意义(P<0.01),对照组与治疗前比较差异无统计学意义(P>0.05)。结论 安非他酮缓释片不但能改善帕金森病抑郁患者情绪,还能改善帕金森病抑郁患者的运动症状和生活质量,值得推广。

[关键词]安非他酮缓释片;抑郁;运动障碍;生活质量

[中图分类号] R749.4 [文献标识码] A [文章编号] 1674-4721(2018)5(a)-0147-04

[Abstract]Objective To compare the efficacy of Bupropion Sustained-Release Tablets and Paroxetine in improving depression and quality of life in the patients with Parkinson′s disease.Methods From February 2016 to September 2017,42 patients with Parkinson′s disease complicated with depression who were were admitted to the outpatient and inpatient in Tai′an Psychiatric Hospital were selected.The random number table was used to divide them into study group and control group,21 patients in each group.The study group was given Bupropion Sustained-Release Tablets for treatment,and the control group was given Paroxetine for treatment.The course of treatment was 6 weeks.The degree of depression changes was assessed by the Hamilton Depression Scale(HAMD).The third subscale of the comprehensive Parkinson′s disease rating Scale (UPDRS) was used to assess motor function.39-item Parkinson′s disease questionnaire (PDQ-39) scores were used to assess the changes in quality of life.Results Before treatment,the scores of HAMD,UPDRS,and PDQ-39 in the two groups of patients were compared,and the differences were not statistically significant(P>0.05).After 2,4,and 6 weeks of treatment,the HAMD scores in both groups were significantly lower than those before treatment,and the differences were statistically significant(P<0.01).There was no statistically significant difference in HAMD scores between the two groups(P>0.05);the third subscale of UPDRS and PDQ-39 score in the study group at 2,4 and 6 weeks were significantly lower than those before treatment(P<0.01).There was no statistically significant difference in the control group compared with that before treatment(P>0.05).Conclusion Bupropion Sustained-Release Tablets can not only improve the depression of the patients with Parkinson′s disease,but also improve the motor symptoms and quality of life in the patients with Parkinson′s disease and depression,which is worthy of promotion.

[Key words]Bupropion Sustained-Release Tablets;Depression;Dyskinesia;Quality of life

帕金森病(PD)是发病率最高的神经变性疾病之一,其典型症状包括静止性震颤、肌强直、运动减少和姿势反应障碍[1]。除运动功能障碍外,PD伴发抑郁(Parkinson′s disease depression,PDD)是PD患者最常见的非运动症状,有报道PD病患者抑郁障碍的发生率为30%~40%[2],严重影响患者的生活质量,增加致残率及社会负担。目前大多数认为选择性5-HT再摄取抑制剂(SSRIs)类抗抑郁药是治疗PDD的主要药物,而SSRIs类药物治疗PDD的疗效并不确定,还可能加重PD的运动症状特别是震颤[3]。安……

登录APP查看全文

猜你喜欢

抑郁生活质量
过半帕金森病会和“抑郁”相伴
整脊疗法对腰椎间盘突出症患者疼痛及生活质量的影响
个体化心理干预对妊娠呕吐孕妇焦虑抑郁的影响
健康教育及心理护理干预对宫颈癌放疗患者负性情绪及生活质量的影响
循证护理策略对乳腺癌患者生存质量的影响评价
护理干预对突发性耳聋患者的影响
围绝经期综合征妇女行护理干预后生活质量的变化研究
产前个性化心理护理对初产妇焦虑、抑郁心理及分娩方式的影响
膳食纤维制剂对老年便秘患者疗效及生活质量的影响
社区中医干预初产妇产后焦虑及抑郁的效果